Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

What is the Immune System?01:38

What is the Immune System?

127.0K
Overview
127.0K
Humoral Immune Responses01:36

Humoral Immune Responses

83.4K
Overview
83.4K
What is Genetic Engineering?00:49

What is Genetic Engineering?

79.7K
Overview
79.7K
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

83.6K
Overview
83.6K
Cells of the Adaptive Immune Response01:23

Cells of the Adaptive Immune Response

8.5K
The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...
8.5K
Cells of the Innate Immune Response01:28

Cells of the Innate Immune Response

8.7K
The innate immune response is an immediate and non-specific response against pathogens, acting swiftly to prevent the spread of infections. The primary cells involved in this response are phagocytes and natural killer (NK) cells.
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
8.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Media analysis reveals the conservation risk of lost and active fishing gear in freshwater ecosystems of Hungary.

Scientific reports·2026
Same author

Screening and validation of Lacticaseibacillus paracasei F50 as a potential biocontrol agent to inhibit Aspergillus flavus in maize: New insights into biocontrol efficacy and mechanisms.

International journal of food microbiology·2026
Same author

Evaluation of microbiological cultures in patients with acute cholecystitis.

Frontiers in surgery·2026
Same author

Quantitative Analysis of the Vitamin D<sub>3</sub> Content in Dietary Supplements Marketed in Hungary Using High-Performance Liquid Chromatography.

Pharmaceuticals (Basel, Switzerland)·2026
Same author

[Two successful thrombectomies in a patient with thrombocytopenia].

Ideggyogyaszati szemle·2026
Same author

Genome-edited safe and immune-evasive human pluripotent cells: Potential solution for allogeneic therapies.

Stem cell reports·2026
Same journal

A guide to CAR T cell therapies: development, current status and future prospects.

Nature reviews. Immunology·2026
Same journal

Macrophages in embryonic development.

Nature reviews. Immunology·2026
Same journal

Glycolytic capacity instructs tumour vasculature and response to immunotherapy.

Nature reviews. Immunology·2026
Same journal

Vaginal NK cells limit epithelial barrier disruption during infection.

Nature reviews. Immunology·2026
Same journal

New insights into progenitor exhausted T cell populations.

Nature reviews. Immunology·2026
Same journal

T cell engagers in autoimmune diseases.

Nature reviews. Immunology·2026
See all related articles

Related Experiment Video

Updated: Jan 20, 2026

Universal and Efficient Electroporation Protocol for Genetic Engineering of Gastrointestinal Organoids
07:19

Universal and Efficient Electroporation Protocol for Genetic Engineering of Gastrointestinal Organoids

Published on: February 18, 2020

18.7K

Engineering universal cells that evade immune detection.

Robert Lanza1, David W Russell2, Andras Nagy3,4,5

  • 1Astellas Institute for Regenerative Medicine, Marlborough, MA, USA. robert.lanza@astellas.com.

Nature Reviews. Immunology
|August 17, 2019
PubMed
Summary
This summary is machine-generated.

Scientists are developing universal donor cells to eliminate immune rejection in transplants. Gene editing and immune-cloaking strategies aim to create

More Related Videos

Stem-cell Based Engineered Immunity Against HIV Infection in the Humanized Mouse Model
11:38

Stem-cell Based Engineered Immunity Against HIV Infection in the Humanized Mouse Model

Published on: July 2, 2016

11.0K
Engineering Cell-permeable Protein
21:08

Engineering Cell-permeable Protein

Published on: December 28, 2009

15.0K

Related Experiment Videos

Last Updated: Jan 20, 2026

Universal and Efficient Electroporation Protocol for Genetic Engineering of Gastrointestinal Organoids
07:19

Universal and Efficient Electroporation Protocol for Genetic Engineering of Gastrointestinal Organoids

Published on: February 18, 2020

18.7K
Stem-cell Based Engineered Immunity Against HIV Infection in the Humanized Mouse Model
11:38

Stem-cell Based Engineered Immunity Against HIV Infection in the Humanized Mouse Model

Published on: July 2, 2016

11.0K
Engineering Cell-permeable Protein
21:08

Engineering Cell-permeable Protein

Published on: December 28, 2009

15.0K

Area of Science:

  • Transplantation Medicine
  • Immunology
  • Regenerative Medicine
  • Gene Editing Technologies

Background:

  • The primary challenge in transplantation is immune rejection, necessitating lifelong immunosuppression.
  • Advancements in stem cell biology and gene editing offer new avenues for creating universally accepted donor cells.
  • Current research focuses on making donor cells 'invisible' to the recipient's immune system.

Purpose of the Study:

  • To explore strategies for developing 'off-the-shelf' universal donor cells for transplantation.
  • To overcome immune rejection and the need for immunosuppressive drugs in cell-based therapies.
  • To review methods for immune evasion and tolerance induction in allogeneic cell therapies.

Main Methods:

  • Genetic manipulation of HLA class I and II genes to reduce immune recognition.
  • Engineering cells to express immune-suppressive molecules like PD-L1 and CTLA4-Ig.
  • Leveraging natural immune-cloaking strategies from pathogens and the fetus.

Main Results:

  • Development of approaches to mask donor cells from immune surveillance.
  • Potential to create universally compatible cells for various therapeutic applications.
  • Progress towards clinical translation of immune-evasive cell therapies.

Conclusions:

  • The creation of universal donor cells is a significant goal in transplantation medicine.
  • Gene editing and immune-cloaking are promising strategies for achieving immune tolerance.
  • Clinical application of these advanced cell therapies is imminent.